CRANFORD, N.J., May 1, 2019 /PRNewswire/ -- Citius
Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty
pharmaceutical company focused on adjunctive cancer care and
critical care drug products, announced today that the Company will
present at the ThinkEquity Conference on Thursday, May 2, 2019 at 8:30AM ET. The conference is being held at The
Mandarin Oriental Hotel in New York
City.
During the conference, Executive Chairman, Mr. Leonard Mazur will be giving the presentation as
well as answering questions from investors. Citius Pharmaceuticals
recently raised $5.3 million with 37%
from coming from Mr. Leonard Mazur,
Executive Chairman of Citius Pharmaceuticals and Mr. Myron Holubiak, President and CEO of Citius
Pharmaceuticals.
Citius Pharmaceuticals, Inc. will also be available for
one-on-one meetings. To arrange a meeting with the Company, please
contact Mr. Andrew Scott: ascott@citiuspharma.com.
About Citius Pharmaceuticals, Inc.
Citius is a
specialty pharmaceutical company dedicated to the development and
commercialization of critical care products, with a focus on
anti-infectives, cancer care and unique prescription products that
use innovative, patented or proprietary formulations of
previously-approved active pharmaceutical ingredients. We seek to
achieve leading market positions by providing therapeutic products
that address unmet medical needs; by using previously approved
drugs with substantial safety and efficacy data, we seek to reduce
the risks associated with pharmaceutical product development and
regulatory requirements. Citius develops products that have
intellectual property protection and competitive advantages to
existing therapeutic approaches. For more information, please
visit www.citiuspharma.com.
Contact:
Andrew
Scott
Vice President, Corporate
Development
(o) 908-967-6677
ascott@citiuspharma.com
View original
content:http://www.prnewswire.com/news-releases/citius-pharmaceuticals-to-present-at-the-thinkequity-conference-300841248.html
SOURCE Citius Pharmaceuticals, Inc.